CVRx, Inc. (CVRX) Research

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.

Market snapshot

Symbol
CVRX
Price
$4.95
Day change
+2.48%
Market cap
$131.4M
P/E ratio
-2.48x
52-week range
4.37-11.3
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$10.00

Peer companies

  • Cerus Corporation (CERS)
  • 908 Devices Inc. (MASS)
  • Nano-X Imaging Ltd. (NNOX)
  • Owens & Minor, Inc. (OMI)
  • ProQR Therapeutics N.V. (PRQR)
  • Quanterix Corporation (QTRX)
  • Senseonics Holdings, Inc. (SENS)
  • Sight Sciences, Inc. (SGHT)

Recent insider activity

  • Nielsen Kirk G. — A-Award (11182 shares) on 2026-06-01
  • Nielsen Kirk G. — A-Award (8720 shares) on 2026-06-01
  • Jain Mudit K. — A-Award (8720 shares) on 2026-06-01
  • Jain Mudit K. — A-Award (11182 shares) on 2026-06-01
  • SLATTERY JOSEPH P — A-Award (8720 shares) on 2026-06-01

Open CVRx, Inc. (CVRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.